arrow
Back
P

P. Joy Ho

Royal Prince Alfred Hospital

36H-index
254Paper Count
1.1WCitation Count
Published Papers 48
Publication Date
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.
err2026-06-24
err0
PREAI
errGemma K. Reynolds; Mark R. Dowling; Safia Belbachir; Nilu Perera; Jian Li; Vinay Vanguru; Benjamin W. Teh; Mary Ann Anderson; Allison Barraclough; Constantine S. Tam; P. Joy Ho; Simon J. Harrison; Andrea S. Henden; Karin A. Thursky; Monica A. Slavin
errShare
errSave
Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry
err2026-06-07
err0
errOAAI
errKenneth J. C. Lim; Elham Ashrafi; Cameron Wellard; Elizabeth M. Moore; Betty Gration; Bradley Augustson; Peter Mollee; Jennifer Zhang; Nicole Wong Doo; Karen Dun; Rachel Cooke; Sabine Ringkowski; Adam Bryant; Georgia McCaughan; Erica Wood; Zoe McQuilten; P. Joy Ho; Hang Quach; Andrew Spencer
errShare
errSave
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma
err2026-05-07
err0
errOAAI
errJoseph P. McGuirk; Armin Ghobadi; Carlos R. Bachier; Paul J. Shaughnessy; Farrukh Awan; Joseph E. Maakaron; Michael R. Bishop; P. Joy Ho; Constantine S. Tam; Michael Dickinson; Justin M. Darrah; Edmund K. Waller; Hemant S. Murthy; Ainsley Ross; Leah M. Williams; Chenyi Pan; William N. Stevens; Laura Serwer; Thao Nguyen; Jonathan Terrett
errShare
errSave
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
errBlood
IF23.1
err2026-02-19
err0
PREAI
errMark R. Dowling; Edward R. Scheffer Cliff; Anthony Jeffrey; Catelyn Cashion; Stephen Boyle; Jian Li; Thomas Buss; Ross MacDonald; Anastasia Edelkina; Hamish W. Scott; Nicole L. O’Leary; Michelle Keir; Safia Belbachir; David A. Westerman; Constantine S. Tam; P. Joy Ho; Simon J. Harrison; Allison Barraclough; Shafqat Inam; Emily Blyth
errShare
errSave
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
err2025-11-08
err0
PREAI
errSueh-li Lim; Cameron Wellard; Rajeev Rajagopal; Simon J. Harrison; Amit Khot; Hang Quach; Phoebe J. Ho; Elizabeth Moore; Erica Wood; Andrew Spencer
errShare
errSave
New Zealand multiple myeloma patients demonstrate inferior outcomes when compared to Australian counterparts – a retrospective cohort study from the Myeloma and Related Diseases Registry (MRDR).
err2025-10-20
err0
errOAAI
errJian Li; Yayehirad Melsew; Cameron Wellard; Elizabeth M Moore; P. Joy Ho; Hang Quach; Simon J Harrison; Rajeev Rajagopal; Bradley Augustson; Erica M Wood; Andrew Spencer
errShare
errSave
Real-world comparison of treatment outcomes for multiple myeloma in elderly transplant ineligible patients receiving first-line VRd, Rd and VCd: Results from the Australian and New Zealand Myeloma and Related Diseases Registry
err2025-08-09
err0
errOAAI
errSarah Zhao; Cameron Wellard; Elizabeth M Moore; Andrew Spencer; Hang Quach; P. Joy Ho; Emma-Jane McDonald; Peter Mollee; Simon J Harrison; Bradley Augustson; Erica M Wood; Zoe K McQuilten; Rajeev Rajagopal
errShare
errSave
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
err2025-08-07
err0
errOAAI
errMaría-Victoria Mateos; Suzanne Trudel; Hang Quach; Paweł Robak; Meral Beksac; Ludek Pour; Marek Hus; Kihyun Kim; Vera Zherebtsova; Sosana Delimpasi; Tomas Jelínek; Christopher Ward; P. Joy Ho; Vladimir Vorobyev; Marcelo Pitombeira de Lacerda; Gracia Aparecida-Martinez; Ivan Spicka; Jakub Radocha; Michele Cavo; Claudio Cerchione
errShare
errSave
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial
err2025-07-15
err0
PREAI
errVania Hungria; Marek Hus; ChengCheng Fu; Vera Zherebtsova; Christopher Ward; P Joy Ho; Damian Mikulski; Ludmila Muronova; Claudio Cerchione; Angely Loubert; Laurine Bunod; Manal M'Hari; Nick Pirooz; Rachel Rogers; Chee Paul Lin; Sumita Roy-Ghanta; Joanna B Opalinska; Molly Purser; Astrid McKeown; Simon McNamara; Hena Baig; Lydia Eccersley; Farrah Pompilus; María-Victoria Mateos
errShare
errSave
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
err2025-07-15
err0
PREAI
errVania Hungria; Paweł Robak; Marek Hus; Vera Zherebtsova; Christopher Ward; P Joy Ho; Roman Hájek; Kihyun Kim; Sebastian Grosicki; Hanlon Sia; Adam Bryant; Marcelo Pitombeira de Lacerda; Gracia Aparecida Martinez; Anna Sureda Balarí; Irwindeep Sandhu; Claudio Cerchione; Peter Ganly; Meletios A Dimopoulos; Chengcheng Fu; Mamta Garg; Al-Ola Abdallah; Moshe E Gatt; Albert Oriol Rocafiguera; Michele Cavo; Robert Rifkin; Tomoaki Fujisaki; Michał Mielnik; Joseph Ficek; Alejandro Mantero; Nick Pirooz; Sybil Varghese; Joe Lee; Astrid McKeown; Rachel Rogers; Hena Baig; Lydia Eccersley; Sumita Roy-Ghanta; Pralay Mukhopadhyay; Jacqueline Nielsen; Joanna Opalinska; María-Victoria Mateos
errShare
errSave
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies
err2025-03-01
err1
PREAI
errAbadir, Edward; Wayte, Rebecca; Li, Wenlong; Gupta, Sachin; Yang, Shihong; Reaiche, Elizabeth; Debosz, Katrina; Anderson, Emily; Favaloro, James; Aklilu, Esther; Brown, Christina; Bryant, Christian; Dunkley, Scott; Mcculloch, Derek; Larsen, Stephen; Rasko, John E. J.; Vanguru, Vinay; Ho, P. Joy
errShare
errSave
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
err2025-01-21
err0
errOAAI
errHo, P. Joy; Quach, Hang; Sidiqi, M. Hasib; Lee, Cindy H.; Butler, Jason; Spencer, Andrew; Micklethwaite, Kenneth; Li, Jingya; Cusson, Elissa; Bagnall, Robert; Harrison, Simon J.
errShare
errSave
Single-cell analysis of the T-cell receptor repertoire in untreated myeloma patients suggests potential myeloma-reactive CD8+ T cells are shared between blood and marrow
err2024-10-03
err0
errOAAI
errFavaloro, James; Bryant, Christian E.; Abadir, Edward; Gardiner, Samuel; Yang, Shihong; King, Tracy; Nassif, Najah; O'Bren, Bronwyn A.; Sedger, Lisa M.; Boyle, Richard; Joshua, Douglas E.; Ho, P. Joy
errShare
errSave
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
err2024-09-17
err0
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
err2024-08-01
err14
PREAI
errHungria, Vania; Robak, Pawel; Hus, Marek; Zherebtsova, Vera; Ward, Christopher; Ho, P. Joy; Ribas de Almeida, Ana Carolina; Hajek, Roman; Kim, Kihyun; Grosicki, Sebastian; Sia, Hanlon; Bryant, Adam; Pitombeira de Lacerda, Marcelo; Aparecida Martinez, Gracia; Sureda Balari, Anna Maria; Sandhu, Irwindeep; Cerchione, Claudio; Ganly, Peter; Dimopoulos, Meletios; Fu, Chengcheng; Garg, Mamta; Abdallah, Al-Ola; Oriol, Albert; Gatt, Moshe E.; Cavo, Michele; Rifkin, Robert; Fujisaki, Tomoaki; Mielnik, Michal; Pirooz, Nick; Mckeown, Astrid; Mcnamara, Simon; Zhou, Xiangdong; Nichols, Maureen; Lewis, Eric; Rogers, Rachel; Baig, Hena; Eccersley, Lydia; Roy-Ghanta, Sumita; Opalinska, Joanna; Mateos, Maria-Victoria
errShare
errSave
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
err2024-07-12
err0
errOAAI
errMollee, Peter; Reynolds, John; Janowski, Wojt; Quach, Hang; Campbell, Philip; Gibbs, Simon; Lee, Sophie; Lee, Edwin; Taylor, Kerry; Cochrane, Tara; Wallington-Gates, Craig; Kwok, Fiona; Weber, Nicholas; Kerridge, Ian; Weston, Helen; Ho, P. Joy; Leahy, Michael Francis; Horvath, Noemi; Spencer, Andrew
errShare
errSave
Flow cytometric immunophenotype of CAR T-cells in pleural fluid and differences with peripheral blood CAR T-cells in a patient with large B-cell lymphoma
err2024-06-01
err0
PREAI
errLi, Eric Wenlong; Aklilu, Esther; Potter, Alison; Yang, Shihong; Ho, P. Joy; Vanguru, Vinay; Abadir, Edward
errShare
errSave
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
err2024-01-25
err106
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; Nijhof, Inger S.; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Sureda Balari, Anna; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Single-cell analysis of the CD8+T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69-subset suggesting potent cytotoxic effectors exist within the tumor bed
err2023-10-05
err3
errOAAI
errFavaloro, James; Bryant, Christian E.; Abadir, Edward; Gardiner, Samuel; Yang, Shihong; King, Tracy; Nassif, Najah; Sedger, Lisa M.; Boyle, Richard; Joshua, Douglas E.; Ho, P. Joy
errShare
errSave
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
err2023-07-27
err230
PREAI
errSan-Miguel, J.; Dhakal, B.; Yong, K.; Spencer, A.; Anguille, S.; Mateos, M. -V.; Fernandez de Larrea, C.; Martinez-Lopez, J.; Moreau, P.; Touzeau, C.; Leleu, X.; Avivi, I.; Cavo, M.; Ishida, T.; Kim, S. J.; Roeloffzen, W.; van de Donk, N. W. C. J.; Dytfeld, D.; Sidana, S.; Costa, L. J.; Oriol, A.; Popat, R.; Khan, A. M.; Cohen, Y. C.; Ho, P. J.; Griffin, J.; Lendvai, N.; Lonardi, C.; Slaughter, A.; Schecter, J. M.; Jackson, C. C.; Connors, K.; Li, K.; Zudaire, E.; Chen, D.; Gilbert, J.; Yeh, T.; Nagle, S.; Florendo, E.; Pacaud, L.; Patel, N.; Harrison, S. J.; Einsele, H.
errShare
errSave